SCHEMBL30255027

SCHEMBL30255027

N#Cc1ccnc2nc[nH]c12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 1/20 0.43
▸ CYP3A5 P20815 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.42
▸ CDC7 O00311 2/20 0.39
▸ DBF4 Q9UBU7 2/20 0.39
▸ BRD4 O60885 3/20 0.39
▸ ROCK2 O75116 2/20 0.38
▸ ROCK1 Q13464 2/20 0.38
▸ CDC42BPA Q5VT25 2/20 0.38
▸ CDC42BPB Q9Y5S2 2/20 0.38
▸ NEK2 P51955 1/20 0.38
▸ LRRK2 Q5S007 3/20 0.38
▸ PI4KA P42356 2/20 0.37
▸ PI4K2B Q8TCG2 2/20 0.37
▸ PI4K2A Q9BTU6 2/20 0.37
▸ PI4KB Q9UBF8 2/20 0.37
▸ LMNA P02545 1/20 0.37
▸ DRD3 P35462 1/20 0.37
▸ XDH P47989 1/20 0.37
▸ HSP90AB1 P08238 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3670084 1.00 CYP3A4 (0.43) CYP3A4CYP3A5ALDH1A1CDC7DBF4
SCHEMBL3152938 0.81 ALDH1A1 (0.47) CYP3A4CYP3A5ALDH1A1BRD4LRRK2
SCHEMBL30495981 0.74 AKT2 (0.44) CDC7DBF4NEK2LRRK2PI4KA
SCHEMBL29031959 0.74 AKT2 (0.44) CDC7DBF4NEK2LRRK2PI4KA
SCHEMBL21263216 0.70 AURKA (0.38) ROCK2ROCK1CDC42BPACDC42BPBLRRK2
SCHEMBL3974202 0.69 ALDH1A1 (0.46) CYP3A4CYP3A5ALDH1A1BRD4LRRK2
SCHEMBL323982 0.69 ALDH1A1 (0.52) CYP3A4CYP3A5ALDH1A1BRD4LRRK2
SCHEMBL22830483 0.69 ALDH1A1 (0.46) CYP3A4CYP3A5ALDH1A1BRD4LRRK2
SCHEMBL1165562 0.69 ALDH1A1 (0.46) CYP3A4CYP3A5ALDH1A1CDC7DBF4
SCHEMBL2493987 0.69 BRD4 (0.51) ALDH1A1BRD4LRRK2PI4KAPI4K2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3752498-B1 SOMATOSTATIN MODULATORS AND USES THEREOF CRINETICS PHARMACEUTICALS INC (US) 2023-06-28 — — EP claimed
EP-3752498-B1 SOMATOSTATIN MODULATORS AND USES THEREOF CRINETICS PHARMACEUTICALS INC (US) 2023-06-28 — — EP disclosed
US-11608335-B2 Somatostatin modulators and uses thereof Crinetics Pharmaceuticals, Inc. (US) 2023-03-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11608335-B2 Somatostatin modulators and uses thereof SSTR5, SSTR2, SSTR4 CYP3A4 4648/4885CYP3A5 4065/4885ALDH1A1 4626/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback